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ABSTRACT
The Launch and Entry Suit (LES) and Advanced Crew Escape Suit
(ACES) are worn by astronauts for launch and entry. Previous work
by Waligora, et al., 1992, Waligora and Gilbert, 1992, and Dalrymple
1996, have found that carbon dioxide (CO2) accumulation in the
LES/ACES helmet may be problematic. CO2 accumulation is
important because high inspired levels of CO2 reduce physical
function and pose a safety hazard (e.g. levels of CO2 accumulation of
3.6% in the Extravehicular Mobility Unit are sufficient to terminate
Extra Vehicular Activities). My task was to design a suitable test
protocol for determining the important physiological aspects of
LES/ACES use. Three basic issues arose. First was the determination
of the astronaut's CO2 inspiration during visor-down use at rest and
during walking at 3.5 mph. A sub-issue was the impact of a
pneumotach on CO2 since it has been previously observed that when
the Aerosport pneumotach was used, performance seemed improved,
which might be attributable to a lowered respiration rate when using
the pneumotach. The second issue was the energy costs of walking
in the LES/ACES with various G-suit inflation levels, since G-suit
inflation increases metabolic costs and metabolic costs influence the
CO2 production in the LES/ACES helmet. Since G-suit inflation
improves orthostatic tolerance after space flight, but likely increases
the energy costs of walking, the balance between G-suit inflation and
CO2 accumulation is an important safety consideration. The third
issue which arose from pilot work was the substantial reduction in
physical function after a 10 min visor-down period prior to walk.
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INTRODUCTION
In the event of an emergency egress after landing, the LES/ACES
serves as a protective garment and together with the integrated
Emergency Oxygen Supply (EOS) provides safe breathing air. Should
a contingency egress be necessary, crew members exit the space
craft with the helmet visor down, breathing 100% 02 from the EOS
and walk/run a distance of 400 meters upwind from the vehicle.
Previously, a pilot study determined the CO2 distribution pattern in
the non-conformal helmet under simulated emergency egress
conditions. During this study, subjects wore the LES with G-suit
inflated to 1.5 psi and visor down, inspiring 100% 02, while
attempting a 5 min walk at 3.5 mph on a treadmill (equivalent to
400 meters).
Those pilot study results showed CO2 build-up in the helmet
occasionally exceeded 7.5%. Three of five subjects were unable to
complete the 5 min walk. Three subjects complained of 02
starvation during the study. These results agree with previous
unpublished findings by Waligora, et al. 1992, Waligora and Gilbert,
1992, who in preliminary tests found that carbon dioxide (CO2)
accumulation in the both conformal and non-conformal helmets could
be problematic. Based on the results of these pilot studies, a follow-
up study is proposed. The prior studies suggested there was a
potential problem with CO2 accumulation, but did not compare the
Aerosport pneumotach, and did not examine the impact of seated
rest immediately before the walk. The 6 min seated rest would
represent the best-case senario since nominal landing procedures at
Kennedy Space Center (KSC) require visor-down above a flight
altitude ofl0k feet (NASA Shuttle entry key cards, NASA Doe.
#48019).
OBJECTIVES
To determine if the inspired CO2 levels are within acceptable ranges
during simulated landing and contingency egress:
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1) What is the % C02 inspired and expired while:
a) seated quietly for 6 min, visor down, in the LES/ACES
(simulating emergency approach and landing period)
while breathing 100% 02?
b) treadmill walking at 3.5 MPH for 5 rain while
wearing the LES/ACES ensemble and breathing 100% 02?
2) What is the % CO2 inspired and expired during above simulated
egress conditions breathing through the Aerosport pneumotaeh in a
manner similar to the Crew Transport Vehicle Locomotion Egress
study, Detailed Supplemental Objective (DSO) 331. Observations
suggest that the pneumotach effects respiration and gas mixing
within the helmet, resulting in lower CO2 inspiration.
3) How does the G-suit inflation level affect the energy costs of
walking at 3.5 mph (5.6 km/hr), 0% grade? (Appropriate use of the
G-suit during ambulation can only be determined by evaluating the
costs and benefits of various G-suit inflations during ambulation).
4) What is the impact on performance of a 6 minute visor-down
period prior to the walk (simulation of nominal landing procedures at
KSC)? And how does a 6 min visor-down rest period affect
performance in an immediately succeeding 5 min walk at 3.5 mph
(similar to DSO 331 with a simulation of visor-down above 10k feet
as per NASA Shuttle entry key cards, NASA Doe. #48019).
MEIHODS
1) Subjects N=12 with physical characteristics similar to the
Astronaut Corps will be drawn from the Exercise Countermeasures
Project and Crew and Thermal Systems Division.
2) Six subjects will be evaluated on each test day. For exarnple, 3
subjects will be tested with the G-suit inflated to 3 clicks (1.5 psi)
and the other half at 0 clicks (each "click" adds 0.5 psi pressure to
the G suit).
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3) Another set of six subjects will be completed on a successive day;
half of the subjects will be tested at 3 clicks of G-suit inflation (1.5
psi) and the other half at 0 clicks. All G-suit inflation levels will be
counterbalanced to avoid ordering effects.
4) On subsequent test days, subjects will be retested in untested G-
suit configurations and rest/walk sequencing (i.e. a crossover design).
This will give us some test-retest reliability information because
some aspects of the test such as seated rest in the LES/ACES will be
replicated exactly.
Goal -- at least 10-12 subjects completed in a month.
Test Protocol
1) Subject will be weighed and instrumented with a heart rate (HR)
monitor, skin and rectal thermocouples and then will don the
LES/ACES. Subject will don a specially configured LES/ACES helmet
with one CO2 sampling capillary located on the microphone boom of
the communications headgear as close as practical to the mouth/nose
routed through the special Aerosport helmet adapter (with the other
adapter openings sealed). Or, for Aerosport pneumotach tests, a
sampling capillary will be located at the pneumotach opening to
determine the impact of the pneumotach on inspired CO2. This is
needed to determine the influence of the pneumotach since it has
been observed that the pneumotach appears to positively influence
the visor-down walk ventilatory performance. This measure could
lead to a solution to anticipated high inspired CO2 levels by altering
the ventilation pattern because of the resistance, thereby reducing
hyper-ventilation. The pneumotach/no-pneumotach order of trials
will be counterbalanced.
Subject will not be cooled, and G-suit will be inflated to the
appropriate G-suit inflation pressure during all walks. All walks will
be at 3.5 mph with visor down, breathing 100% O2 until a subject
reaches one of the limiting criteria:
a) Completion of 5 min. walk
b) Upon subject request
c) Upon reaching 6% inspired CO2 level
d) Achievement of 90% of age-predicted HR max.
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2) After all instruments are functionally verified, subject will be
evaluated in one of the following tests:
Phase I- Immediately after visor-down, subject will walk with
(or without, in counterbalanced order) the pneumotach for 5 min,
and CO2 and respiratory rate will be monitored to determine the
impact of the pneumotach on performance and inspired CO2 levels.
G-suit will be inflated to 0 or 1.5 psi in counterbalanced order. The
two different G-suit inflations will be tested on different days.
Phase II- Subjects will perform 6 min of seated, rest
immediately prior to walking as in Phase I, except the two G-suit
pressures will be 0.5 and 1.0 psi (counterbalanced order). No helmet
ventilation will be provided between the rest and walk to simulate
an egress evacuation of the shuttle with appropriate CO2
accumulation prior to the walking phase. The two different G-suit
inflations will be tested on different days with order
counterbalanced.
Phase III- Replication of Phase II with 0 and 1.5 psi G-suit
inflation, in counterbalanced Order.
3) Following each Phase walk, the visor will be immediately opened,
and the subject will be connected to the suit cooling system.
4) When the subject is ready, she/he will walk again at 3.5 mph at
theG-suit inflated to the appropriate pressure for that test Phase,
visor up, in order to determine the energy costs of LES/ACES
locomotion with the G-suit setting at 0 through 1.5 psi. The
additional energy costs of walking with the G-suit inflated can
thereby be determined. After this walk which will require
approximately 3 to 5 min, subject will again be seated and permitted
tO recover.
Rest periods between any two test walks will be a minimum of 10
minutes. However, subjects may recover as long as they desire.
Liquid cooling and drinking water will be provided during rest.
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CO2 will be measured continuously with the Perkin-Elmer mass
spectrometer whose analog outputs are connected to a CODAS data
collection system. VO2 will be measured with the Aerosport (only in
the visor-up configuration). Temperatures will be measured with
the Squirrel data collection system. Data collection sheets are shown
in Appendix A.
Preliminary results
A pilot study of LES/ACES helmet CO2 accumulations was conducted
on three subjects during June 1996. The first two subjects, "A" and
"B" were measured walking with and without the Aerosport
mouthpiece and during rest. The complete LES was not worn, but
only the neck dam and helmet supplied with 100% O2. The treadmill
was elevated to elicit a metabolic rate of 1.7 L/rain, similar to the
LES with G-suit not inflated (Barrows, et al., 1995), but speed was
kept at 3.5 mph. The third subject, "#1" was fully outfitted with G-
suit inflated to 1.5 psi. The entire Phase I protocol as proposed was
completed with G-suit at 1.5 psi. Findings for the helmet-only
simulation are displayed in Table 1.
Table 1. Pilot study results for helmet-only simulation.
Inspired CO2 at rest (%):
Subject (trial) minl min2 min3 min4 min5
A (w/o pneum) 1.6 1.6 1.8 1.7 1.6
A (w pneum) 1.6 1.7 1.6 1.6 1.6
B (w/o pneum) 2.0 1.8 2.2 2.1 2.0
B (w pneum) 2.0 1.9 1.9 1.8 1.9
Inspired CO2 during 3.5 mph walk (%):
Subject minl min2 min3 min4 min5
A (w/o pneum) 2.5 2.7 3.0 3.1 3.5
A (w pneum ) 2.3 2.9 3.4 3.3 3.2
B (w/o pneum) 2.5 2.9 2.7 2.7 2.8
B (w pneum) 2.3 2.5 2.7 2.9 3.0
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The actual LES pilot walk was conducted on 26 June 1996. A full LES
inflated to 1.5 psi was used. The subject was healthy, highly fit and
experienced in LES use. After 30 see of visor-down 10 rain rest
period, CO2 inspired had risen from a nominal 0.3% (ambient) to an
average of 1.6 (sd=0.21)% (regardless of pneumotach use). During
the last 2 min of rest, inspired CO2 was 1.6 (0.16) (regardless of
pneumotach use). This indicates high test-retest reliability for this
phase of testing.
Without the pneumotach, immediately following the 10 rain rest
period, the subject was able to walk only 100 seconds at 3.5 mph.
Average inspired CO2 over the whole walk was 3.0% (0.84). With the
pneumotach, the subject was able to walk only 120 seconds at 3.5
mph. Average inspired CO2 was 2.3 (0.63)%. Average respiratory
rate was 27.3 breaths per rain without the pneumotaeh, and 23.6
with the pneumotach. In both walks, heart rate reached about 160
bpm (84% of predicted maximum). On a previous occasion under the
same conditions, this subject was able to walk 300 seconds without
the 10 min visor-down rest immediately preceding the walk (from
Dalrymple, in progress).
Based upon all these pilot results it was concluded that during the
walking part of the test, the pneumotach appears to reduce the
inspired CO2 (by 30%) and respiratory rate (by 16%), and slightly
increase endurance (by 20%). Although this effect was not clearly
seen in the simulation (Subjects A and B), in the actual LES the
pneumotach appears to exert some effect. Both subjects, A and B
were able to complete 5 rain walk in the helmet alone. Most
importantly, in the LES, the 5 to 6 min period which might be
expected between visor-down order on the Kennedy Space Center
landing checklist and the start of contingency egress could reduce
performance capabilities.
Expected findings
Based upon the above pilot work and that of previous investigators,
it is anticipated that the following will be observed:
a) That inspired CO2 levels will rapidly exceed 1% under all
conditions and will exceed 4% in most subjects during walking. The
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rise in CO2 will be proportional to the metabolic rate. In the EMU, 3
to 8 mmHG of CO2 with symptoms, or greater than 8 without
symptoms, terminates EVA. At EMU pressure (4.3 psi or 222
mmHG), 3 mmHg of CO2 is equivalent to 1.3%, and 8 mmHg of CO2 is
equivalent to 3.6%. The impact of 1-4% CO2 on physical performance
during LES/ACES walking is unknown.
b) That the use of the Aerosport pneumotach will reduce the
ventilation rate such to slow the rate of increase in inspired CO2 and
increase performance.
c) That the metabolic costs of G-suit inflation will be
significantly higher and linearly increase with G-suit inflation
pressure (i.e. the energy costs of walking with 0.5 psi G-suit inflation
will be substantially higher than 0 psi).
d) It is anticipated that a substantial number of rested, fit, 1G-
acclimatized subjects will be unable to walk 5 min at 3.5 mph, with
the visor down and G-suit inflated to 1.5 psi. The 6 min visor-down
rest period will further reduce the walk-completion success rate for
all G-suit levels.
DISCUSSION
Comparisons between the pressure suits worn by military pilots of
high-altitude aircraft and US astronauts could be potentially
misleading. The USAF SR-71 pressure suit is similar to the LES/ACES.
However, the SR-71 suit has no neck dam, and uses a conformal
helmet with less dead space and an exhale port near the mouth. The
LES/ACES has a neck dam, and uses a non-conformal helmet.
Aircrews generally spend the majority of their time sitting quietly
and in emergency they eject. In contrast, in contingency egress,
Shuttle crews must physically leave the shuttle under their own
power. Active egress is a crucial safety issue.
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Appendix A
Data Collection Sheet for CO2 Helmet Study Summer 1996
Name Date
Age HT _ in _ cm Wt _ lbs __ KG
G-Suit setting psi Resting HR
6 Min seated rest Visor Down
bpm
Seated HR Initial Tre
T calf
CO2 : min 1 _, min2
min 5 __, min 6
min 9 , Final
m, Tback _, Tarm _, Tthigh _,
_, min 3 min 4 _,
min 7 _, min 8 _,
Final HR
Subject's Comments
nvestigator's Comments
***Recovery Visor-up under some test conditions, immediate walk
for others***
Walk 3.5 mph 0% grade Visor Down, G-suit inflated
Standing HR _ Initial Tre m, Tback
T calf
CO2 : min 1 _., min 2____.__, min 3
Final Final HR Ve Rate
Subject's Comments
, Tarm _, Tthigh _,
min 4 _,
b/min
psi
Investigator's Comments
REST PERIOD- with cooling and visor up
Time begin
Seated HR __ Initial Tre __, Tback __, Tarm __, Tthigh __,
T calf Final seated HR
Time end elapsed time
Subject's Comments
min
Investigator's Comments
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Name Date
Walk 3.5 mph 0% grade Visor Down With Aerosport
pneumotach and nose clip, G-suit inflated psi
Standing HR _ Initial Tre m., Tback
T calf
CO2 : min 1 _, min 2______, min 3
CO2 Final Final HR
m, Tarm m, Tthigh _,
min 4 _,
Ve Rate b/min
Subject's Comments
Investigator's Comments
REST PERIOD- with Cooling and visor up
Time begin
Seated HR
T calf
Initial Tre _, Tback _, Tarrn __, Tthigh _,
Final HR
Time end elapsed time
Subject's Comments
min
Investigator's Comments
VO2 measured walk Visor UP, G-suit inflated psi
Standing HR _ Initial Tre _, Tback _, Tarm m, Tthigh _,
T calf _ VO2 Initial (stand)_, min 1 _, min 2_.______,
min 3, min 4 _, Final Final HR Ve Rate
b/min
Subject's Comments
Investigator's Comments
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LES/ACES Non-Conformal Helmet CO2 Concentrations
Questionnaire
Name Date
1) Did you have any feeling of breathlessness during any phase of
testing? Which?
2) Did you feel any phase of the testing was particularly demanding?
Which?
3) Did you have any feelings of anxiety, headache, drowsiness,
nausea or any other unusual feelings during any phase of testing?
What? Which?
4) Did you find any phase of testing physically demanding? Which?
What body part?
5) Do you have any additional comments regarding this testing?
6) Other
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